View our poster on Assessing Comorbid Inflammatory Arthritis Conditions and Swollen to Tender Joint Count Ratios in a Real-World Systemic Lupus Erythematosus Cohort. Click to view more!
August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]
Thu. Sep 10, 2020 2:00 PM – 3:00 PM EDT Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with autoimmune diseases where diagnosis can be difficult and there is no cure. Despite the promises of RWD to improve our understanding of the natural history of these diseases and to[…]
May 28, 2020 11:00 AM – 12:00 PM In the midst of a pandemic, healthcare providers and regulators are hyper-focused on Covid-19. But, moving research forward in other conditions is still critical and does not need to come to a halting stop. Join us as we explore: – Enabling real-world research and registries while healthcare[…]
Published by TechCrunch, December 17 2019, written by Jonathan Shieber OM1, a big-data analytics company for the healthcare industry, has raised $50 million in its latest round of financing to expand its sales and marketing and product development activities as it brings clinical insights to hospitals and big pharma companies alike. The new financing highlights[…]
